MicroStrategy
MSTR
英偉達
NVDA
Adobe
ADBE
賽富時
CRM
蘋果
AAPL
美股市場個股詳情
BIAF bioAffinity Technologies
- 0.993
- -0.187-15.86%
收盤價 12/20 16:00 (美東)
- 1.010
- +0.017+1.73%
盤後 20:01 (美東)
1547.24萬總市值-1.24市盈率TTM
1.290最高價0.982最低價47.89萬股成交量1.240今開1.180昨收51.49萬成交額4.45%換手率虧損市盈率(靜)1558.46萬總股本3.62052周最高4.96市淨率1069.11萬流通值0.83152周最低--股息TTM1076.86萬流通股15.550歷史最高--股息率TTM26.10%振幅0.831歷史最低1.075平均價1股每手
關於bioAffinity Technologies公司
bioAffinity Technologies Inc 致力於解決早期癌症和肺部疾病無創診斷以及靶向癌症治療的需求。公司使用能夠優先靶向癌細胞和指示疾病狀態的細胞羣體的技術開發專有的無創診斷測試和癌症治療藥物。公司的產品CyPath Lung是一種用於檢測早期肺癌的無創測試。
公司介紹
公司代碼BIAF
公司名稱bioAffinity Technologies
上市日期2022/09/01
發行價格6.12
成立日期2014
CEOMs. Maria Zannes, J.D.
所屬市場納斯達克
員工數量75
年結日12-31
公司地址22211 West Interstate 10,Suite 1206
城市San Antonio
省份德克薩斯州
國家美國
郵編78257
電話1-210-698-5334
董事高管
- 姓名
- 職務
- 年薪
- Maria Zannes, J.D.
- President, Chief Executive Officer and Director
- 42.42萬
- Dr. Vivienne Rebel, M.D.
- Executive Vice President, Chief Science and Medical Officer
- --
- Xavier Trinidad Reveles
- Chief Operating Officer
- --
- J. Michael Edwards, C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Timothy P. Zannes, J.D.
- Executive Vice President, Secretary and General Counsel
- --
- Steven Girgenti
- Executive Chairman of the Board
- 24.87萬
- Roby P. Joyce, M.D.
- Director
- 2.50萬
- Stuart Diamond
- Independent Director
- 10.50萬
- Robert A. Anderson
- Independent Director
- 10.00萬
- Peter S. Knight
- Independent Director
- 10.25萬
- Dr. Jamie Platt, PhD
- Independent Director
- --
- Gary Rubin
- Independent Director
- 10.25萬